Edwards Lifesciences Corp. (EW)
90.79
+0.05
(+0.06%)
USD |
NYSE |
Sep 02, 16:00
90.79
0.00 (0.00%)
After-Hours: 19:41
Edwards Lifesciences Research and Development Expense (TTM) : 1.091B for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.091B |
| March 31, 2026 | 1.088B |
| December 31, 2025 | 1.079B |
| September 30, 2025 | 1.083B |
| June 30, 2025 | 1.055B |
| March 31, 2025 | 1.051B |
| December 31, 2024 | 1.053B |
| September 30, 2024 | 1.024B |
| June 30, 2024 | 1.013B |
| March 31, 2024 | 985.30M |
| December 31, 2023 | 989.80M |
| September 30, 2023 | 979.90M |
| June 30, 2023 | 970.70M |
| March 31, 2023 | 977.80M |
| December 31, 2022 | 945.20M |
| September 30, 2022 | 945.80M |
| June 30, 2022 | 950.20M |
| March 31, 2022 | 924.70M |
| December 31, 2021 | 903.10M |
| September 30, 2021 | 866.00M |
| June 30, 2021 | 823.50M |
| March 31, 2021 | 780.30M |
| December 31, 2020 | 760.70M |
| September 30, 2020 | 758.90M |
| June 30, 2020 | 758.90M |
| Date | Value |
|---|---|
| March 31, 2020 | 768.70M |
| December 31, 2019 | 752.70M |
| September 30, 2019 | 721.90M |
| June 30, 2019 | 688.20M |
| March 31, 2019 | 650.40M |
| December 31, 2018 | 622.20M |
| September 30, 2018 | 605.70M |
| June 30, 2018 | 586.80M |
| March 31, 2018 | 567.10M |
| December 31, 2017 | 552.60M |
| September 30, 2017 | 520.90M |
| June 30, 2017 | 491.00M |
| March 31, 2017 | 469.10M |
| December 31, 2016 | 442.20M |
| September 30, 2016 | 425.50M |
| June 30, 2016 | 413.50M |
| March 31, 2016 | 398.50M |
| December 31, 2015 | 383.10M |
| September 30, 2015 | 368.90M |
| June 30, 2015 | 355.50M |
| March 31, 2015 | 347.10M |
| December 31, 2014 | 346.50M |
| September 30, 2014 | 341.10M |
| June 30, 2014 | 337.60M |
| March 31, 2014 | 329.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Stryker Corp. | 1.606B |
| Intuitive Surgical, Inc. | 1.414B |
| Abbott Laboratories | 3.128B |
| Zimmer Biomet Holdings, Inc. | 442.90M |
| Solventum Corp. | 715.00M |